$10 Million Available to Support Innovative Cancer Research Projects
PHILADELPHIA - The American Association for Cancer Research reminds the cancer research community that the Letters of Intent deadline for Stand Up To Cancers Innovative Research Grants (IRG) is less than two weeks away.
The IRG Letters of Intent submission deadline is 12:00 p.m. ET on Monday, Nov. 15, 2010.
IRGs will support the next generation of extraordinary cancer research leaders in their quest to conquer cancer by providing funding of up to $750,000 over a three-year period.
Those interested should submit Letters of Intent detailing their best ideas for cutting-edge research projects on all forms of cancer, using the proposal website, which can be found at: https://proposalcentral.altum.com.
IRGs offer financial support to scientists pursuing novel, high-risk, but potentially high-reward cancer research proposals that have significant potential for translational application and hold great promise for advancing SU2Cs goal of improving and saving lives. Proposals may focus on any discipline within basic, translational or clinical research, provided that these criteria are met.
The Innovative Research Grants program was established in honor of the late Judah Folkman, M.D., to recognize him as one of the great innovators in cancer research, an outstanding teacher of young investigators, and an early contributor to the SU2C project.
The AACR, as SU2Cs sole scientific partner, is responsible for administering these grants and, through the Scientific Advisory Committee and Innovative Research Grants Committee, provides ongoing scientific oversight to ensure that progress is being made.
IRG recipients will be announced in April of 2011.
For general information on eligibility criteria, the nomination process and other details about the Innovative Research Grants, please visit: www.aacr.org/IRG. Or direct your inquiries to the SU2C Grants Office at: (267) 765-1049 or email@example.com.
# # #
The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, the AACR is the worlds oldest and largest professional organization dedicated to advancing cancer research. The membership includes 32,000 basic, translational and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and more than 90 other countries. The AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs. It funds innovative, meritorious research grants, research fellowships and career development awards. The AACR Annual Meeting attracts more than 18,000 participants who share the latest discoveries and developments in the field. Special conferences throughout the year present novel data across a wide variety of topics in cancer research, treatment and patient care. Including Cancer Discovery, the AACR publishes seven major peer-reviewed journals: Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; Cancer Epidemiology, Biomarkers & Prevention; and Cancer Prevention Research. AACR journals represented 20 percent of the market share of total citations in 2009. The AACR also publishes CR, a magazine for cancer survivors and their families, patient advocates, physicians and scientists.